Future of drugs-Diabetes_Ranirestat

Drug Name
Ranirestat
Structure
 
Drug Code
AS-3201
Synonym
(3R)-2'-(4-bromo-2-fluorobenzyl)-1'H,2H,5H-spiro[pyrrolidine-3,4'-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetrone
Molecular Formula
C17H11BrFN3O4
Innovator
Dainippon Sumitomo Pharma
PharmaKyorin
Condition
Diabetic nephropathy (Orphan drug status)
Mechanism of Action
Aldose reductase inhibitor
Clinical Phase
III in USA

Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’